Health Canada has finalized the second phase of its modernization of the Medical Device Establishment Licence (MDEL) regime. On June 17, 2026, the federal government published the Regulations Amending the Medical Devices Regulations (SOR/2026-110) in the Canada Gazette, Part II. The amendments will come into force on December 14, 2026, providing industry stakeholders with approximately six months to prepare for compliance.
New MDEL requirements and exemptions come into force December 14, 2026
The amendments introduce three significant changes to Canada's medical device regulatory framework:
- Certain foreign distributors will no longer be required to hold an MDEL.
- MDEL holders will be required to provide supplier information to Health Canada as part of the licensing process.
- Manufacturers, importers, and distributors will be expressly required to establish, implement, and maintain documented procedures relating to key safety and compliance activities.
While the amendments reduce licensing burdens for some businesses, they also enhance Health Canada's visibility into the medical device supply chain and strengthen the department's ability to verify compliance during inspections.
Companies involved in the manufacture, importation, or distribution of medical devices in Canada should assess the impact of these changes well in advance of the December 2026 implementation date.
1. Foreign distributors benefit from a new MDEL exemption
One of the most significant amendments is removing the duplicative licensing requirement that previously applied to many foreign distributors.
What is changing?
Under the previous framework, foreign distributors often required their own MDEL in addition to the MDEL held by the Canadian importer, resulting in duplicative licensing obligations in many supply chains. Under the amended rules, a foreign distributor is exempt from holding its own MDEL provided it sells exclusively through a Canadian importer or distributor that holds an MDEL.
The amendment better aligns Canada with other major jurisdictions, including the United States, the European Union, the United Kingdom, and Australia.
Important limitation
The exemption is not universal. Foreign distributors will still require their own MDEL where they sell medical devices directly to persons in Canada who do not hold an MDEL, such as healthcare facilities or retailers.
Practical implications
Multinational medical device companies should review their current licensing structures to determine whether affiliated foreign distributors may be able to rely on a Canadian importer's MDEL following the coming-into-force date.
In some cases, the amendment may permit consolidation of existing licensing arrangements and corresponding reductions in administrative burden.
2. Supplier list disclosure becomes a mandatory requirement
To maintain oversight of medical device supply chains, Health Canada has formalized supplier reporting requirements.
What is changing?
The amendments require all MDEL applicants to submit a supplier list at the time of initial application and to update the list annually at the time of their annual licence reviews. The list must identify every person (other than the manufacturer) from whom the MDEL holder obtains medical devices. The supplier list must include:
- The supplier's name.
- The supplier's address.
- The risk classification of the devices supplied.
Any application that remains under review when the amendments come into force must also be updated to include the required supplier information before an MDEL can be issued.
Confidential business information
Recognizing the commercial sensitivity of supplier relationships, Health Canada has indicated that supplier information provided under the new requirements will be treated as confidential business information.
Practical implications
Organizations should begin identifying all suppliers and gathering the information required for disclosure. Companies should also review supplier and distribution agreements to ensure they permit disclosure of supplier information to regulatory authorities where necessary for compliance purposes.
3. Documented safety procedures become an express regulatory requirement
The amendments also strengthen regulatory requirements relating to compliance and safety-management procedures.
What is changing?
Previously, MDEL applicants were generally required to attest that documented procedures existed for certain safety-related activities. The amended regulations expressly require manufacturers, importers, and distributors to establish, implement, and maintain documented procedures addressing activities such as distribution records; complaint handling; recalls and corrective actions; provision of information concerning serious risks of injury to human health; handling, storage, delivery and installation; and servicing activities, where applicable. The amendments close an enforcement gap identified by Health Canada during inspections.
Practical implications
The amendments provide Health Canada with a clearer regulatory basis for assessing compliance during inspections, requiring, for example, that documented procedures be maintained for distribution records and for ensuring effective investigations and recalls. Organizations should ensure not only that written procedures exist, but that they are current, implemented in practice, and appropriately supported by records demonstrating ongoing compliance.
Updated Health Canada Guidance expected
Health Canada has indicated that the following guidance documents will be revised to reflect the amended regulatory requirements:
- GUI-0016 – Guidance on Medical Device Establishment Licensing
- GUI-0064 – How Health Canada Inspects Medical Device Establishments
- GUI-0079 – Risk Classification Guide for Medical Device Establishment Inspections
- FRM-0292 – MDEL Application Instructions
Preparing for December 14, 2026
Organizations involved in the Canadian medical device market should consider taking the following steps before the amendments come into force:
- Review foreign distributor licensing arrangements to determine whether existing MDELs remain necessary.
- Compile and validate supplier information required for future MDEL applications and annual licence reviews.
- Ensure documented procedures required under the Medical Device Regulations are updated and in place.
The author wishes to thank Haris Djedovic and Grace Hobson, students at law, for their contribution to preparing this legal update.